文献速递瓣膜外科

低危患者经导管主动脉瓣植入与外科主动脉瓣置换的倾向评分匹配分析

Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis.
PubMed 文献 · Eur J Cardiothorac Surg · 2019-01-01

本研究比较了低危(EuroSCORE II <4%)患者接受经导管主动脉瓣植入(TAVI)与外科主动脉瓣置换(SAVR)的结局。

要点

  • 低危患者TAVI与SAVR的30天死亡率无显著差异。
  • TAVI组永久起搏器植入率和≥中度瓣周漏显著高于SAVR组。
  • TAVI组3年和5年生存率显著低于SAVR组。

核心结论

  • 在低危患者中,TAVI短期结局与SAVR相似,但永久起搏器植入和≥中度瓣周漏发生率更高,长期生存更差。
  • TAVI组较差的长期结局可归因于该人群合并症更多。

研究设计与样本

  • 单中心回顾性研究,纳入EuroSCORE II <4%接受经股动脉TAVI(2008-2016年,n=955)或SAVR(2009-2014年,n=886)的患者。

主要发现

  • 30天死亡率SAVR vs TAVI为1.1% vs 1.8%(P=1.0)。
  • 永久起搏器植入率SAVR vs TAVI为0.0% vs 14.8%(P<0.001)。
  • ≥中度瓣周漏发生率SAVR vs TAVI为0.0% vs 7.0%(P=0.017)。
  • 术后有效瓣口面积和跨瓣压差无差异。
  • 1年生存率两组相似,但TAVI组3年和5年生存率显著更低。

临床怎么用

  • 对于低危主动脉瓣狭窄患者,选择TAVI需权衡起搏器植入和瓣周漏风险及长期生存可能更差。
  • 在广泛推广TAVI至年轻低危患者前,需等待随机对照试验的长期结果。

局限性

  • 为单中心回顾性研究,样本量有限,可能存在选择偏倚。
  • TAVI组合并症更多可能影响长期生存比较。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The aim of the study was to determine the differences in outcomes of surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) in low-risk patients. METHODS: All patients with a logistic EuroSCORE II <4% who underwent transfemoral TAVI between 2008 and 2016 (n = 955) or SAVR between 2009 and 2014 (n = 886) at our centre were included. One hundred and nine patients per group were available for propensity score matching. RESULTS: Mortality during the 30-day follow-up showed no differences (SAVR vs TAVI: 1.1% vs 1.8%, P = 1.0) but the rates of permanent pacemaker implantation (0.0 vs 14.8%, P < 0.001) and paravalvular leakage ≥ moderate (0.0 vs 7.0%, P = 0.017) were higher in TAVI patients. No difference was found regarding postoperative effective orifice area and transvalvular pressure gradients. Although, the 1-year survival was similar between both groups; 3- and 5-year survival was significantly inferior in the TAVI patient cohort. CONCLUSIONS: TAVI yielded similar short-term outcomes compared with SAVR despite higher rates of permanent pacemaker implantation and paravalvular leakage ≥ moderate, but inferior long-term survival. Poorer long-term outcomes of the TAVI patient cohort were attributable to a more comorbid TAVI population. This emphasizes the need for long-term results from randomized controlled trials before TAVI can be broadly expanded to younger low-risk patients.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Schaefer A, Schofer N, Goßling A, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2019. PMID: 31566209. doi:10.1093/ejcts/ezz245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。